|
1
|
El-Serag HB and Rudolph KL: Hepatocellular
carcinoma: Epidemiology and molecular carcinogenesis.
Gastroenterology. 132:2557–2576. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Callegari E, Gramantieri L, Domenicali M,
D'Abundo L, Sabbioni S and Negrini M: MicroRNAs in liver cancer: A
model for investigating pathogenesis and novel therapeutic
approaches. Cell Death Differ. 22:46–57. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Xie W, Qin W, Kang Y, Zhou Z and Qin A:
MicroRNA-340 inhibits tumor cell proliferation and induces
apoptosis in endometrial carcinoma cell line RL 95–2. Med Sci
Monit. 22:1540–1546. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhang M, Zhuang Q and Cui L: MiR-194
inhibits cell proliferation and invasion via repression of RAP2B in
bladder cancer. Biomed Pharmacother. 80:268–275. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Jin L, Li Y, Liu J, Yang S, Gui Y, Mao X,
Nie G and Lai Y: Tumor suppressor miR-149-5p is associated with
cellular migration, proliferation and apoptosis in renal cell
carcinoma. Mol Med Rep. 13:5386–5392. 2016.PubMed/NCBI
|
|
6
|
Wang N, Wang Q, Shen D, Sun X, Cao X and
Wu D: Downregulation of microRNA-122 promotes proliferation,
migration, and invasion of human hepatocellular carcinoma cells by
activating epithelial-mesenchymal transition. Onco Targets Ther.
9:2035–2047. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chen L, Guan H, Gu C, Cao Y, Shao J and
Wang F: miR-383 inhibits hepatocellular carcinoma cell
proliferation via targeting APRIL. Tumour Biol. 37:2497–2507. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhang Q, Zhao S, Pang X and Chi B:
MicroRNA-381 suppresses cell growth and invasion by targeting the
liver receptor homolog-1 in hepatocellular carcinoma. Oncol Rep.
35:1831–1840. 2016.PubMed/NCBI
|
|
9
|
Massoumi R: CYLD: A deubiquitination
enzyme with multiple roles in cancer. Future Oncol. 7:285–297.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Massoumi R, Chmielarska K, Hennecke K,
Pfeifer A and Fässler R: Cyld inhibits tumor cell proliferation by
blocking Bcl-3-dependent NF-kappaB signaling. Cell. 125:665–677.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ni F, Gui Z, Guo Q, Hu Z, Wang X, Chen D
and Wang S: Downregulation of miR-362-5p inhibits proliferation,
migration and invasion of human breast cancer MCF7 cells. Oncol
Lett. 11:1155–1160. 2016.PubMed/NCBI
|
|
12
|
Pannem RR, Dorn C, Ahlqvist K, Bosserhoff
AK, Hellerbrand C and Massoumi R: CYLD controls c-MYC expression
through the JNK-dependent signaling pathway in hepatocellular
carcinoma. Carcinogenesis. 35:461–468. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tauriello DV, Haegebarth A, Kuper I,
Edelmann MJ, Henraat M, Canninga-van Dijk MR, Kessler BM, Clevers H
and Maurice MM: Loss of the tumor suppressor CYLD enhances
Wnt/beta-catenin signaling through K63-linked ubiquitination of
Dvl. Mol Cell. 37:607–619. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yang G, Zhang X and Shi J: MiR-98 inhibits
cell proliferation and invasion of non-small cell carcinoma lung
cancer by targeting PAK1. Int J Clin Exp Med. 8:20135–20145.
2015.PubMed/NCBI
|
|
15
|
Lv H, Zhang Z, Wang Y, Li C, Gong W and
Wang X: MicroRNA-92a promotes colorectal cancer cell growth and
migration by inhibiting KLF4. Oncol Res. 23:283–290. 2016.
View Article : Google Scholar
|
|
16
|
Shen F, Cai WS, Feng Z, Li JL, Chen JW,
Cao J and Xu B: MiR-492 contributes to cell proliferation and cell
cycle of human breast cancer cells by suppressing SOX7 expression.
Tumour Biol. 36:1913–1921. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Xie BH, He X, Hua RX, Zhang B, Tan GS,
Xiong SQ, Liu LS, Chen W, Yang JY, Wang XN, et al: Mir-765 promotes
cell proliferation by downregulating INPP4B expression in human
hepatocellular carcinoma. Cancer Biomark. 16:405–413. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhou X, Zhu HQ, Ma CQ, Li HG, Liu FF,
Chang H and Lu J: MiR-1180 promoted the proliferation of
hepatocellular carcinoma cells by repressing TNIP2 expression.
Biomed Pharmacother. 79:315–320. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chen JS, Li HS, Huang JQ, Dong SH, Huang
ZJ, Yi W, Zhan GF, Feng JT, Sun JC and Huang XH: MicroRNA-379-5p
inhibits tumor invasion and metastasis by targeting FAK/AKT
signaling in hepatocellular carcinoma. Cancer Lett. 375:73–83.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhou X, Zhang L, Zheng B, Yan Y, Zhang Y,
Xie H, Zhou L, Zheng S and Wang W: MicroRNA-761 is upregulated in
hepatocellular carcinoma and regulates tumorigenesis by targeting
Mitofusin-2. Cancer Sci. 107:424–432. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Urbanik T, Köhler BC, Boger RJ, Wörns MA,
Heeger S, Otto G, Hövelmeyer N, Galle PR, Schuchmann M, Waisman A,
et al: Down-regulation of CYLD as a trigger for NF-κB activation
and a mechanism of apoptotic resistance in hepatocellular carcinoma
cells. Int J Oncol. 38:121–131. 2011.PubMed/NCBI
|
|
22
|
Guo J, Shinriki S, Su Y, Nakamura T,
Hayashi M, Tsuda Y, Murakami Y, Tasaki M, Hide T, Takezaki T, et
al: Hypoxia suppresses cylindromatosis (CYLD) expression to promote
inflammation in glioblastoma: Possible link to acquired resistance
to anti-VEGF therapy. Oncotarget. 5:6353–6364. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ke H, Augustine CK, Gandham VD, Jin JY,
Tyler DS, Akiyama SK, Hall RP and Zhang JY: CYLD inhibits melanoma
growth and progression through suppression of the JNK/AP-1 and
β1-integrin signaling pathways. J Invest Dermatol. 133:221–229.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hellerbrand C, Bumes E, Bataille F,
Dietmaier W, Massoumi R and Bosserhoff AK: Reduced expression of
CYLD in human colon and hepatocellular carcinomas. Carcinogenesis.
28:21–27. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liang HL, Hu AP, Li SL, Xie JP, Ma QZ and
Liu JY: MiR-454 prompts cell proliferation of human colorectal
cancer cells by repressing CYLD expression. Asian Pac J Cancer
Prev. 16:2397–2402. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Huang DH, Wang GY, Zhang JW, Li Y, Zeng XC
and Jiang N: MiR-501-5p regulates CYLD expression and promotes cell
proliferation in human hepatocellular carcinoma. Jpn J Clin Oncol.
45:738–744. 2015. View Article : Google Scholar : PubMed/NCBI
|
